Literature DB >> 2800976

Halothane-induced variability in the neuromuscular transmission of patients with myasthenia gravis.

E Nilsson1, M Paloheimo, K Müller, J Heinonen.   

Abstract

The purpose of the present clinical study was to explore the skeletal muscle mechano (MMG)- and electromyographic (EMG) responses during halothane/oxygen/air anaesthesia in patients with myasthenia gravis (MG) compared with patients with normal neuromuscular transmission. The majority of MG-patients had a significant decremental response of the evoked muscle action potentials to a train-of-four (TOF) stimulation during halothane exposure (mean decrease of train-of-four ratio was 33% during the highest mean halothane concentration of 1.9 MAC). An excellent correlation was found between MMG- and EMG-measurements (r2 = 0.878, P less than 0.001). However, marked individual variations in the neuromuscular response to halothane were seen. Neither preoperative muscle fatigability nor acetylcholine receptor antibodies predicted the decremental muscle responses produced by halothane among MG-patients. The increased presence of HLA-B8 among myasthenics with halothane-suppressed muscle responses after TOF stimulation could be demonstrated (P less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2800976     DOI: 10.1111/j.1399-6576.1989.tb02931.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  9 in total

1.  Neuromuscular effects of sevoflurane in a patient with Myasthenia Gravis.

Authors:  M Nishi; H Nakagawa; R Komatsu; T Natsuyama; Y Tanaka
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

2.  Sevoflurane-induced sensitivity of neuromuscular function in a patient with myasthenia gravis in true remission.

Authors:  J Takeda; Y Ohnishi; T Koitabashi; K Fukushima
Journal:  J Anesth       Date:  1997-06       Impact factor: 2.078

Review 3.  Anaesthesia and myasthenia gravis.

Authors:  A Baraka
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

4.  Multivariate determinants of the need for postoperative ventilation in myasthenia gravis.

Authors:  M Naguib; A A el Dawlatly; M Ashour; E A Bamgboye
Journal:  Can J Anaesth       Date:  1996-10       Impact factor: 5.063

5.  Neuromuscular effects of sevoflurane in patients with myasthenia gravis.

Authors:  T Morita; H Tsukagoshi; D Kurosaki; T Sugaya; D Yoshikawa; H Shimada
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

6.  Total intravenous anesthesia with propofol for thymectomy in a patient with myasthenia gravis.

Authors:  J A Roelofse; P J Roth
Journal:  Anesth Prog       Date:  1993

7.  Rapid inhalation induction with halothane-nitrous oxide for myasthenic patients.

Authors:  P P Ruiz-Neto; H Halpern; E Cremonesi
Journal:  Can J Anaesth       Date:  1994-02       Impact factor: 5.063

8.  Anaesthetic considerations in paediatric myasthenia gravis.

Authors:  Oliver William Masters; Oliver N Bagshaw
Journal:  Autoimmune Dis       Date:  2011-09-25

9.  Use of ProSeal(®) LMA and thoracic epidural in myasthenia patients for trans-sternal thymectomy: A case series.

Authors:  Binu Puthur Simon; Salil G Nair; Gauravjit Singh Paik; Khin Lay Nyi
Journal:  Indian J Anaesth       Date:  2015-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.